Avantor (AVTR) Other Non-Current Assets (2018 - 2026)
Avantor's (AVTR) quarterly Other Non-Current Assets came in at $441.7 million in Q1 2026, up 20.19% year-on-year from $367.5 million in Q1 2025, and up 11.54% quarter-over-quarter from $396.0 million in Q4 2025.
Avantor (AVTR) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Avantor's Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $441.7 million for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 20.19% year-over-year to $441.7 million in Q1 2026; TTM through Mar 2026 was $441.7 million, a 20.19% increase from a year earlier, with the FY2025 full-year figure at $396.0 million, up 9.88% from the prior year.
- Other Non-Current Assets climbed to $441.7 million in Q1 2026 per AVTR's latest filing, from $396.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $441.7 million in Q1 2026 and bottomed at $216.5 million in Q3 2024.
- The 5-year median for Other Non-Current Assets is $358.3 million (2023), against an average of $326.8 million.
- Across the five-year window, Other Non-Current Assets retreated 25.14% in 2024 and soared 87.39% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $293.5 million in 2022, then gained by 22.08% to $358.3 million in 2023, then advanced by 0.59% to $360.4 million in 2024, then rose by 9.88% to $396.0 million in 2025, then gained by 11.54% to $441.7 million in 2026.
- Per Business Quant, the three latest AVTR Other Non-Current Assets figures stand at $441.7 million (Q1 2026), $396.0 million (Q4 2025), and $405.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Avantor | 7.67 Bn | 7.39 Bn | 500.70 Mn | 441.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 441.70 Mn |
| Dec 31, 2025 | 396.00 Mn |
| Sep 30, 2025 | 405.70 Mn |
| Jun 30, 2025 | 390.90 Mn |
| Mar 31, 2025 | 367.50 Mn |
| Dec 31, 2024 | 360.40 Mn |
| Sep 30, 2024 | 216.50 Mn |
| Jun 30, 2024 | 368.10 Mn |
| Mar 31, 2024 | 367.70 Mn |
| Dec 31, 2023 | 358.30 Mn |
| Sep 30, 2023 | 289.20 Mn |
| Jun 30, 2023 | 276.70 Mn |
| Mar 31, 2023 | 272.50 Mn |
| Dec 31, 2022 | 293.50 Mn |
| Sep 30, 2022 | 244.60 Mn |
| Jun 30, 2022 | 254.80 Mn |
| Mar 31, 2022 | 252.00 Mn |
| Dec 31, 2021 | 233.10 Mn |
| Sep 30, 2021 | 240.00 Mn |
| Jun 30, 2021 | 244.60 Mn |